Colleen F Reitan insider trades

Open-market stock purchases and sales by Colleen F Reitan, Director at Myriad Genetics Inc, from SEC Form 4 filings since Jun 1, 2018.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -15%.

Recent trades

DateStockTradeValue
Jun 4, 2026MYGN Myriad Genetics IncBought (not open market)—
May 20, 2026ALNY Alnylam Pharmaceuticals, IncBought (not open market)—
May 20, 2026ALNY Alnylam Pharmaceuticals, IncBought (not open market)—

Companies traded

  • MYGN Myriad Genetics Inc: 1 sale, last Jun 4, 2026
  • ALNY Alnylam Pharmaceuticals, Inc: 2 buys, 17 sales, last May 20, 2026

Get free alerts when Colleen F Reitan files a new trade →